6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
Just now	Press Release Apr 29 2026
2m ago	Colgate, in partnership with Hong Kong Dental Association, launches TOTAL Periodontal Health Lab
28m ago	Navios Maritime Partners L.P. Announces First Day of Trading of Bonds at Euronext Oslo Børs
29m ago	Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model
29m ago	Fiverr Announces First Quarter 2026 Results

About

Wuxi Biologics (HK:2269) — investor relations, events, news, and company updates on 6ix.

Latest News

WuXi Biologics Chengdu Microbial Commercial Manufacturing Site Achieves Structural Completion and Key Equipment Arrival

WuXi Biologics Receives South Korea MFDS GMP Certification to Enable Commercial Manufacturing of Bispecific Antibody Therapeutics

WuXi Biologics Recognized by Morningstar Sustainalytics as Industry and Regional ESG Leader for Sixth Year

WuXi Biologics Achieves ISO 13485 Certification, Signifying Strong Capabilities in Drug-Device Combination Product Development and Manufacturing

WuXi Biologics Honored with CDMO Leadership Awards for Ninth Consecutive Year

Financials

Revenue

HK$21.79 B

Market Cap

HK$144.59 B

P/E Ratio

26.50

EPS

0.99

Community Chat

Ask AI